# Nouscom

> Developing cancer immunotherapies

Business model and tags: Has physical offices, Venture-backed, Pharma & life sciences

## About Nouscom

A clinical stage immuno-oncology company developing off-the-shelf and personalized cancer immunotherapies using proprietary viral vectors with high immunogenicity in patients

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 51–250 employees
- **Headquarters**: Basel City, Switzerland
- **Revenue**: CHF 15.4M – CHF 121M (Tamtam estimate)
- **Website**: [nouscom.com](http://www.nouscom.com/)
- **LinkedIn**: [linkedin.com/company/nouscom-ag](https://www.linkedin.com/company/nouscom-ag)

## Nouscom at a glance

Nouscom is a company in the Biotechnology Research industry, headquartered in Basel City, Switzerland.

Nouscom has 51–250 employees.

Nouscom's revenue is CHF 15.4M – CHF 121M (Tamtam estimate).

## Frequently asked questions about Nouscom

### What is Nouscom's revenue?

Tamtam estimates Nouscom's annual revenue at CHF 15.4M – CHF 121M.

### How many employees does Nouscom have?

Nouscom has 51–250 employees.

### Where is Nouscom headquartered?

Nouscom is headquartered in Basel City, Switzerland.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/nouscom